Identification and quantification of 4-methylethcathinone (4-MEC) and 3,4-methylenedioxypyrovalerone (MDPV) in hair by LC–MS/MS after chronic administration
- 1 January 2017
- journal article
- case report
- Published by Elsevier in Forensic Science International
- Vol. 270, 39-45
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Bath salts and synthetic cathinones: An emerging designer drug phenomenonLife Sciences, 2014
- An automated method for measurement of methoxetamine in human plasma by use of turbulent flow on-line extraction coupled with liquid chromatography and mass spectrometric detectionAnalytical and Bioanalytical Chemistry, 2012
- Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive ‘Bath Salts’ ProductsNeuropsychopharmacology, 2012
- Ultra high performance liquid chromatography–electrospray ionization–tandem mass spectrometry screening method for direct analysis of designer drugs, “spice” and stimulants in oral fluidJournal of Chromatography A, 2012
- Prevalence of new psychoactive substances: A retrospective study in hairDrug Testing and Analysis, 2012
- Death Following Recreational Use of Designer Drug “Bath Salts” Containing 3,4-Methylenedioxypyrovalerone (MDPV)Journal of Medical Toxicology, 2012
- 3,4-Methylenedioxypyrovalerone (MDPV): Chemistry, pharmacology and toxicology of a new designer drug of abuse marketed onlineToxicology Letters, 2012
- Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United StatesClinical Toxicology, 2011
- Identification and characterization of the new designer drug 4′-methylethcathinone (4-MEC) and elaboration of a novel liquid chromatography–tandem mass spectrometry (LC–MS/MS) screening method for seven different methcathinone analogsForensic Science International, 2011
- Urine Analysis of 3,4-Methylenedioxypyrovalerone in Opioid-Dependent Patients by Gas Chromatography–Mass SpectrometryTherapeutic Drug Monitoring, 2011